NOVELION THERAPEUTICS INC.·4

Oct 10, 4:06 PM ET

Harshbarger Benjamin 4

4 · NOVELION THERAPEUTICS INC. · Filed Oct 10, 2017

Insider Transaction Report

Form 4
Period: 2017-10-06
Harshbarger Benjamin
General Counsel and Secretary
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-10-06+75,00075,000 total
    Exercise: $7.03Exp: 2027-10-06Common Shares (75,000 underlying)
Footnotes (2)
  • [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
  • [F2]The options shall vest and become exercisable in three equal annual installments on October 6, 2018, October 6, 2019 and October 6, 2020.

Documents

1 file
  • 4
    a4.xmlPrimary

    4